April 27th, 2007
Enzyme Predicts Survival and Recurrence of Nasopharyngeal Cancer
An enzyme that can be used to predict the survival and recurrence rates for nasopharyngeal cancer have been isolated by Mayo Clinic Cancer Center scientists and collaborating Chinese researchers.
SULF2, a recently identified heparin-degrading endosulfatase, appears to be significantly overexpressed in nasopharyngeal cancers, providing hope of the eventual ability to predict recurrence and subsequent prognosis after […]
Recent Comments